世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

分子診断市場:用途毎(感染症:肝炎・エイズ、がん、遺伝子検査)、技術毎(PCR、DNAシーケンシング、次世代シーケンシング)、エンドユーザ毎(病院、学術研究所)、製品・サービス毎(試薬、ソフトウェア) - 2023年までの世界市場予測

Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2018年5月US$5,650
シングルユーザライセンス
241 259

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の分子診断市場に関する調査レポートです。

“The global molecular diagnostics market is projected to grow at a CAGR of 8.4%.”

The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are expected to restrain the growth of this market during the forecast period.

“The reagents & kits segment to dominate the molecular diagnostics market, by product & service in 2018.”

Based on product and service, the molecular diagnostics market is segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncology), increase in basic research and commercial applications, and easy accessibility to a wide range of reagents.

“The market in the Asia Pacific region is projected to register the highest CAGR during the forecast period.”

Asia Pacific is expected to register the highest CAGR in the global molecular diagnostics market during the forecast period. Market growth in the Asia Pacific is attributed to growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).

Break-up profile of primaries:

• By Company Type - Tier I: 40%, Tier II: 30%, and Tier III: 30%
• By Designation - C-level: 27%, D-level: 18%, and Others: 55%
• By Region - North America: 50%, Europe: 20%, Asia Pacific: 20%, and the RoW: 10%

The key players operating in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).

Research coverage:

In this report, the molecular diagnostics market is segmented on the basis of product & service, application, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and core competencies in the molecular diagnostics market.

Reasons to buy this report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global molecular diagnostics market. The report analyzes the market, by product & service, application, technology, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global molecular diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for molecular diagnostic products across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global molecular diagnostics market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global molecular diagnostics market
     


目次

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.2.1 MARKETS COVERED 23
1.2.2 YEARS CONSIDERED FOR THE STUDY 24
1.3 CURRENCY 24
1.4 LIMITATIONS 24
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 PRIMARY DATA 27
2.1.1 KEY DATA FROM PRIMARY SOURCES 27
2.1.2 KEY INDUSTRY INSIGHTS 28
2.2 SECONDARY DATA 29
2.2.1 KEY DATA FROM SECONDARY SOURCES 29
2.3 MARKET SIZE ESTIMATION 30
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.4.1 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 39
4.1 MOLECULAR DIAGNOSTICS: MARKET OVERVIEW 39
4.2 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND REGION, 2018 40
4.3 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE,
2018 VS. 2023 (USD BILLION) 40
4.4 MOLECULAR DIAGNOSTICS MARKET, BY END USER 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 High prevalence of infectious diseases and various types of cancers 43
5.2.1.2 Increasing awareness and acceptance of personalized medicine and companion diagnostics 43
5.2.1.3 Growth in the biomarker identification market and advancements in molecular techniques 43

5.2.2 RESTRAINTS 44
5.2.2.1 Complex regulatory frameworks delaying the approval of new molecular diagnostic tests 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Advances in genomics and proteomics 44
5.2.3.2 Growth opportunities in emerging markets 45
5.2.4 CHALLENGES 46
5.2.4.1 Dearth of trained professionals limiting the appropriate use of new molecular diagnostic technologies 46
6 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 47
6.1 INTRODUCTION 48
6.2 REAGENTS & KITS 48
6.3 INSTRUMENTS 51
6.4 SERVICES & SOFTWARE 54
7 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 58
7.1 INTRODUCTION 59
7.2 POLYMERASE CHAIN REACTION (PCR) 60
7.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 63
7.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) 66
7.5 IN SITU HYBRIDIZATION 69
7.6 DNA MICROARRAY 72
7.7 OTHER TECHNOLOGIES 74
8 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 78
8.1 INTRODUCTION 79
8.2 INFECTIOUS DISEASES 80
8.2.1 HEPATITIS 84
8.2.2 HIV 85
8.2.3 CT/NG 86
8.2.4 HAIS 87
8.2.5 HPV 88
8.2.6 TUBERCULOSIS 89
8.2.7 INFLUENZA 90
8.2.8 OTHER INFECTIOUS DISEASES 91
8.3 ONCOLOGY 91
8.3.1 BREAST CANCER 95
8.3.2 COLORECTAL CANCER 95
8.3.3 LUNG CANCER 96
8.3.4 PROSTATE CANCER 97
8.3.5 OTHER CANCERS 97

8.4 GENETIC TESTS 98
8.5 OTHER APPLICATIONS 101
9 MOLECULAR DIAGNOSTICS MARKET, BY END USER 104
9.1 INTRODUCTION 105
9.2 HOSPITAL & ACADEMIC LABORATORIES 106
9.3 REFERENCE LABORATORIES 109
9.4 OTHER END USERS 112
10 MOLECULAR DIAGNOSTICS MARKET, BY REGION 115
10.1 INTRODUCTION 116
10.2 NORTH AMERICA 117
10.2.1 US 120
10.2.2 CANADA 123
10.3 EUROPE 125
10.3.1 GERMANY 128
10.3.2 FRANCE 131
10.3.3 ITALY 133
10.3.4 SPAIN 135
10.3.5 UK 137
10.3.6 REST OF EUROPE 140
10.4 ASIA PACIFIC 142
10.4.1 JAPAN 146
10.4.2 CHINA 148
10.4.3 AUSTRALIA 151
10.4.4 INDIA 153
10.4.5 ROAPAC 155
10.5 REST OF THE WORLD 157
10.5.1 LATIN AMERICA 159
10.5.1.1 Brazil 162
10.5.1.2 Mexico 164
10.5.1.3 Rest of Latin America 167
10.5.2 MIDDLE EAST & AFRICA 168
11 COMPETITIVE LANDSCAPE 171
11.1 OVERVIEW 171
11.2 MARKET SHARE ANALYSIS 172
11.3 MOLECULAR DIAGNOSTICS MARKET COMPETITIVE SHARE ANALYSIS, BY APPLICATION 173
11.3.1 MARKET SHARE ANALYSIS FOR INFECTIOUS DISEASE APPLICATIONS 173
11.3.2 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY 174
11.3.2.1 Polymerase Chain Reaction (PCR) 174
11.3.2.2 DNA sequencing and NGS 174
11.3.2.3 In Situ Hybridization (ISH) 175
11.4 COMPETITIVE SITUATION AND TRENDS 175
11.4.1 NEW PRODUCT LAUNCHES AND APPROVALS, 2016–2018 175
11.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016–2018 176
11.4.3 ACQUISITIONS AND MERGERS 177
11.4.4 EXPANSIONS 177
12 COMPANY PROFILES 178
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 ABBOTT LABORATORIES 178
12.2 AGILENT TECHNOLOGIES 182
12.3 BECTON, DICKINSON AND COMPANY 188
12.4 BIOMÉRIEUX SA 193
12.5 DANAHER CORPORATION 197
12.6 DIASORIN 202
12.7 GRIFOLS 206
12.8 HOLOGIC 209
12.9 ILLUMINA 212
12.10 QIAGEN 216
12.11 ROCHE DIAGNOSTICS 221
12.12 SIEMENS AG 225
12.13 THERMO FISHER SCIENTIFIC 228

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 233
13.1 DISCUSSION GUIDE 233
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 236
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 238
13.4 AVAILABLE CUSTOMIZATIONS 239
13.5 RELATED REPORTS 239
13.6 AUTHOR DETAILS 240

 

LIST OF TABLES

TABLE 1 NEW TESTS LAUNCHED BY KEY PLAYERS 45
TABLE 2 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 48
TABLE 3 MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION,
2016–2023 (USD MILLION) 48
TABLE 4 NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 49
TABLE 5 EUROPE: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 49
TABLE 6 ASIA PACIFIC: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 50
TABLE 7 ROW: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION,
2016–2023 (USD MILLION) 50
TABLE 8 LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 50
TABLE 9 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 51
TABLE 10 NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 52
TABLE 11 EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 52
TABLE 12 ASIA PACIFIC: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 53
TABLE 13 ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 14 LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 53
TABLE 15 MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 54
TABLE 16 NORTH AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 55
TABLE 17 EUROPE: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 55
TABLE 18 ASIA PACIFIC: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 56
TABLE 19 ROW: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY REGION, 2016–2023 (USD MILLION) 56
TABLE 20 LATIN AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 57
TABLE 21 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 60
TABLE 22 MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION,
2016–2023 (USD MILLION) 61
TABLE 23 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR,
BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 24 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR PCR,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 61
TABLE 25 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR PCR,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 62
TABLE 26 ROW: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION,
2016–2023 (USD MILLION) 62
TABLE 27 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 63
TABLE 28 MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION,
2016–2023 (USD MILLION) 63
TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY, 2016–2023 (USD MILLION) 64
TABLE 30 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 64
TABLE 31 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 65
TABLE 32 ROW: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION,
2016–2023 (USD MILLION) 65
TABLE 33 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 65
TABLE 34 MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS,
BY REGION, 2016–2023 (USD MILLION) 66
TABLE 35 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 36 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 67
TABLE 37 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 68
TABLE 38 ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS,
BY REGION, 2016–2023 (USD MILLION) 68
TABLE 39 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 68
TABLE 40 MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY REGION, 2016–2023 (USD MILLION) 69
TABLE 41 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2016–2023 (USD MILLION) 70
TABLE 42 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 70
TABLE 43 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 71
TABLE 44 ROW: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY REGION, 2016–2023 (USD MILLION) 71
TABLE 45 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 71
TABLE 46 MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION,
2016–2023 (USD MILLION) 72
TABLE 47 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 48 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 73
TABLE 49 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 73
TABLE 50 ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY REGION, 2016–2023 (USD MILLION) 74
TABLE 51 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 74
TABLE 52 MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2016–2023 (USD MILLION) 75
TABLE 53 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 54 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 76
TABLE 55 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 76
TABLE 56 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2016–2023 (USD MILLION) 77
TABLE 57 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 77
TABLE 58 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 79
TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2016–2023 (USD MILLION) 80
TABLE 60 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 81
TABLE 61 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 81
TABLE 62 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 82
TABLE 63 ROW: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY REGION, 2016–2023 (USD MILLION) 82
TABLE 64 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 83
TABLE 65 MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY DISEASE TYPE, 2016–2023 (USD MILLION) 83
TABLE 66 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 84
TABLE 67 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION TESTS) 84
TABLE 68 HIV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 85
TABLE 69 HIV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION TESTS) 85
TABLE 70 CT/NG DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 86
TABLE 71 CT/NG DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION TESTS) 86
TABLE 72 HAI DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 87
TABLE 73 HAI DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION TESTS) 87
TABLE 74 HPV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 88
TABLE 75 HPV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION TESTS) 88
TABLE 76 TB DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 89
TABLE 77 TB DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION TESTS) 89
TABLE 78 INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 90
TABLE 79 INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION TESTS) 90
TABLE 80 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 91
TABLE 81 MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION,
2016–2023 (USD MILLION) 92
TABLE 82 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY, 2016–2023 (USD MILLION) 92
TABLE 83 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 93
TABLE 84 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 93
TABLE 85 ROW: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY REGION, 2016–2023 (USD MILLION) 94
TABLE 86 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 94
TABLE 87 MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY CANCER TYPE,
2016–2023 (USD MILLION) 94
TABLE 88 BREAST CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 95
TABLE 89 COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 96
TABLE 90 LUNG CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 96
TABLE 91 PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 97
TABLE 92 OTHER CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 98
TABLE 93 MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION,
2016–2023 (USD MILLION) 98
TABLE 94 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 95 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 99
TABLE 96 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 100
TABLE 97 ROW: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY REGION, 2016–2023 (USD MILLION) 100
TABLE 98 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 100
TABLE 99 MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 101
TABLE 100 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 101
TABLE 101 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 102
TABLE 102 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 102
TABLE 103 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY REGION, 2016–2023 (USD MILLION) 103
TABLE 104 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 103
TABLE 105 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 105
TABLE 106 MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 106
TABLE 107 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 107
TABLE 108 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 107
TABLE 109 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 108
TABLE 110 ROW: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 108
TABLE 111 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 108
TABLE 112 MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES,
BY REGION, 2016–2023 (USD MILLION) 109
TABLE 113 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 109
TABLE 114 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 110
TABLE 115 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 110
TABLE 116 ROW: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES,
BY REGION, 2016–2023 (USD MILLION) 111
TABLE 117 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 111
TABLE 118 MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION,
2016–2023 (USD MILLION) 112
TABLE 119 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY, 2016–2023 (USD MILLION) 112
TABLE 120 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 113
TABLE 121 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 113
TABLE 122 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION) 114
TABLE 123 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 114
TABLE 124 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 117
TABLE 125 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 118
TABLE 126 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 119
TABLE 127 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 119
TABLE 128 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2015–2023 (USD MILLION) 120
TABLE 129 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 120
TABLE 130 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 121
TABLE 131 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 122
TABLE 132 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 122
TABLE 133 US: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 122
TABLE 134 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 123
TABLE 135 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 124
TABLE 136 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 124
TABLE 137 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 125
TABLE 138 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 126
TABLE 139 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 126
TABLE 140 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 127
TABLE 141 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 127
TABLE 142 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 128
TABLE 143 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 129
TABLE 144 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 129
TABLE 145 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 130
TABLE 146 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 130
TABLE 147 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 131
TABLE 148 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 131
TABLE 149 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 132
TABLE 150 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 132
TABLE 151 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 133
TABLE 152 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 133
TABLE 153 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 134
TABLE 154 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2015–2023 (USD MILLION) 134
TABLE 155 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 135
TABLE 156 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 136
TABLE 157 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 136
TABLE 158 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2015–2023 (USD MILLION) 137
TABLE 159 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2015–2023 (USD MILLION) 138
TABLE 160 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 138
TABLE 161 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 139
TABLE 162 UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 139
TABLE 163 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 140
TABLE 164 ROE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 140
TABLE 165 ROE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 141
TABLE 166 ROE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 141
TABLE 167 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 143
TABLE 168 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 144
TABLE 169 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 144
TABLE 170 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 145
TABLE 171 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 145
TABLE 172 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 146
TABLE 173 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 147
TABLE 174 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 147
TABLE 175 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 148
TABLE 176 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 149
TABLE 177 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 149
TABLE 178 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 150
TABLE 179 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 150
TABLE 180 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 151
TABLE 181 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 151
TABLE 182 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 152
TABLE 183 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 152
TABLE 184 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 153
TABLE 185 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 154
TABLE 186 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 154
TABLE 187 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 155
TABLE 188 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 155
TABLE 189 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 156
TABLE 190 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 156
TABLE 191 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 157
TABLE 192 ROW: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 157
TABLE 193 ROW: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 158
TABLE 194 ROW: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 158
TABLE 195 ROW: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 159
TABLE 196 ROW: MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 159
TABLE 197 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 160
TABLE 198 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2016–2023 (USD MILLION) 160
TABLE 199 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 161
TABLE 200 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET,
BY END USER, 2016–2023 (USD MILLION) 161
TABLE 201 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 161
TABLE 202 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 162
TABLE 203 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 163
TABLE 204 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 163
TABLE 205 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 164
TABLE 206 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 165
TABLE 207 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 165
TABLE 208 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 166
TABLE 209 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 166
TABLE 210 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 167
TABLE 211 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 167
TABLE 212 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 168
TABLE 213 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 168
TABLE 214 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 169
TABLE 215 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2016–2023 (USD MILLION) 169
TABLE 216 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 170
TABLE 217 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET,
BY END USER, 2016–2023 (USD MILLION) 170
TABLE 218 NEW PRODUCT LAUNCHES AND APPROVALS, 2016–2018 175
TABLE 219 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016–2018 176
TABLE 220 ACQUISITIONS AND MERGERS 2016–2018 177
TABLE 221 EXPANSIONS, 2016–2018 177

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 26
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 29
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 31
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 31
FIGURE 5 DATA TRIANGULATION 32
FIGURE 6 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE, 2018 VS. 2023 34
FIGURE 7 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018 VS. 2023 35
FIGURE 8 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018 VS. 2023 36
FIGURE 9 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018 VS. 2023 37
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR DIAGNOSTICS MARKET 38
FIGURE 11 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND VARIOUS TYPES OF CANCERS — KEY DRIVERS FOR THE MARKET 39
FIGURE 12 PCR TECHNOLOGY TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018 40
FIGURE 13 REAGENTS AND KITS TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET
IN 2023 40
FIGURE 14 HOSPITAL AND ACADEMIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE IN 2018 41
FIGURE 15 MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 42
FIGURE 16 DNA SEQUENCING & NGS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018–2023) 59
FIGURE 17 GEOGRAPHICAL SNAPSHOT: ASIA PACIFIC TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE MOLECULAR DIAGNOSTICS MARKET 116
FIGURE 18 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 118
FIGURE 19 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 143
FIGURE 20 COMPANIES ADOPTED PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 171
FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2017 172
FIGURE 22 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RANKING,
BY KEY PLAYER, 2017 173
FIGURE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE ANALYSIS, BY KEY PLAYER 2016 174
FIGURE 24 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016 174
FIGURE 25 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR ISH, BY KEY PLAYER, 2016 175
FIGURE 26 ABBOTT LABORATORIES: COMPANY SNAPSHOT 178
FIGURE 27 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT 182
FIGURE 28 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 188
FIGURE 29 BIOMÉRIEUX SA: COMPANY SNAPSHOT 193
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT 197
FIGURE 31 DIASORIN: COMPANY SNAPSHOT 202
FIGURE 32 GRIFOLS: COMPANY SNAPSHOT 206
FIGURE 33 HOLOGIC: COMPANY SNAPSHOT 209
FIGURE 34 ILLUMINA: COMPANY SNAPSHOT 212
FIGURE 35 QIAGEN: COMPANY SNAPSHOT (2017) 216
FIGURE 36 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 221
FIGURE 37 SIEMENS AG: COMPANY SNAPSHOT 225
FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 228
 

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Molecular Diagnostics Market worth 11.54 Billion USD by 2023


May 24, 2018

The report "Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023", The global molecular diagnostics market is expected to reach USD 11.54 Billion by 2023 from USD 7.71 Billion in 2018, at a CAGR of 8.4%. The high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques are some of the key factors driving the growth of this market.

Based on technology, the PCR segment is expected to account for the largest share of the market in 2018

On the basis of technology, the market is broadly segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. The PCR segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment is attributed to the growing use of PCR in proteomics and genomics, automation of PCR instruments, and the emergence of advanced technologies like qRT-PCR.

The infectious diseases segment is expected to account for the largest share of the molecular diagnostics market, by application, in 2018

On the basis application, the market is broadly segmented into infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment is attributed to the development of advanced assays for different diseases and conditions, significant increase in the prevalence of infectious diseases, and rising awareness about the effective use of molecular diagnostic technologies to control the occurrence and spread of infectious diseases.

Hospital & academic laboratories are the largest end users of the molecular diagnostics market

On the basis of end user, the market is broadly segmented into hospitals and academic laboratories, reference laboratories, and other end users. The hospitals and academic laboratories segment is expected to account for the largest share of the market in 2018. The large share of this segment can primarily be attributed to the large number of diagnostic tests conducted in hospitals.

North America to dominate the molecular diagnostics market in 2018

In 2018, North America is expected to account for the largest share of the global molecular diagnostics market. The large share of this region is mainly attributed to the high prevalence of infectious diseases and cancers, presence of a highly developed healthcare system and large number of leading national clinical laboratories, easy accessibility to technologically advanced instruments in the region, availability of government funds, and growing applications of molecular diagnostics in genetic disorders and cancer screening.

The key players in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).

 

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る